Clearside Biomedical's Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting

Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - Title: Suprachoroidal Drug Delivery in the Real World Presented by: Glenn Yiu , M.D., PhD Summary: Additional Presentations Delivered by Clearside Commercial and Development Partners ALPHARETTA, Ga., June 12, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced t ...